MacroGenics
MGNX
$4.36
Share price
-14.75%
Change (1 day)
-28.44%
Change (1 year)
Categories
MacroGenics (MGNX) - Total assets
Total assets on the balance sheet as of December 2023 : $0.29 B
According to MacroGenics's latest financial reports the company's total assets are $0.29 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
MacroGenics - Total assets on balance sheet (from 2012 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.29 B | 6.4% |
| 2022-12-31 | $0.28 B | -16.34% |
| 2021-12-31 | $0.33 B | -11.48% |
| 2020-12-31 | $0.37 B | 21.2% |
| 2019-12-31 | $0.31 B | -5.91% |
| 2018-12-31 | $0.33 B | -11.17% |
| 2017-12-31 | $0.37 B | 20.12% |
| 2016-12-31 | $0.31 B | -13.36% |
| 2015-12-31 | $0.35 B | 106.61% |
| 2014-12-31 | $0.17 B | 38.24% |
| 2013-12-31 | $0.12 B | 134.03% |
| 2012-12-31 | $53.74 M | -14.25% |
| 2011-12-31 | $62.68 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $226.50 B | 75,800.58% | 🇺🇸 USA |
 Eli Lilly LLY | $63.94 B | 21,327.49% | 🇺🇸 USA |
 Amgen AMGN | $97.15 B | 32,456.35% | 🇺🇸 USA |
 Gilead Sciences GILD | $62.12 B | 20,718.11% | 🇺🇸 USA |
 Merck MRK | $106.67 B | 35,646.84% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $99.03 B | 33,085.33% | 🇺🇸 USA |
 Xencor XNCR | $0.95 B | 219.25% | 🇺🇸 USA |